ScholarIQanswers from OpenAlex
Fondazione IRCCS Istituto Nazionale dei Tumori
InstitutionResearch output, impact & collaborations
Fondazione IRCCS Istituto Nazionale dei Tumori is a institution indexed in ScholarIQ from OpenAlex.
What is known about Fondazione IRCCS Istituto Nazionale dei Tumori?
ScholarIQrecord summary
Fondazione IRCCS Istituto Nazionale dei Tumori is a research organisation in Milan, IT. OpenAlex records 27,272 works and 3,675,489 citations for it. 4,131 researchers list it as their most recent affiliation.
How many works does Fondazione IRCCS Istituto Nazionale dei Tumori have?
ScholarIQindexed works
Fondazione IRCCS Istituto Nazionale dei Tumori has 27,272 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Fondazione IRCCS Istituto Nazionale dei Tumori have?
ScholarIQcitation count
Fondazione IRCCS Istituto Nazionale dei Tumori has 3,675,489 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Fondazione IRCCS Istituto Nazionale dei Tumori?
ScholarIQresearcher count
Fondazione IRCCS Istituto Nazionale dei Tumori has 4,131 researchers in the ScholarIQ index.
What is the average h-index at Fondazione IRCCS Istituto Nazionale dei Tumori?
ScholarIQavg h-index
Fondazione IRCCS Istituto Nazionale dei Tumori has an average h-index of 70 in OpenAlex.
What is the ROR of Fondazione IRCCS Istituto Nazionale dei Tumori?
ScholarIQror
The ROR for Fondazione IRCCS Istituto Nazionale dei Tumori is on the source record.
What is the OpenAlex record for Fondazione IRCCS Istituto Nazionale dei Tumori?
ScholarIQopenalex
The OpenAlex for Fondazione IRCCS Istituto Nazionale dei Tumori is on the source record.
Who are the most-cited researchers behind Fondazione IRCCS Istituto Nazionale dei Tumori?
ScholarIQtop researchers by citations
What are the most-cited papers on Fondazione IRCCS Istituto Nazionale dei Tumori?
ScholarIQmost cited works
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Ray McDermott, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Giuseppe Procopio, Elizabeth R. Plimack, Daniel Castellano, Toni K. Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A.B. Schutz, Christian Kollmannsberger, James Larkin, Alain Ravaud, Jason S. Simon, Li-An Xu, Ian M. Waxman, Padmanee Sharma
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro, Josep M. Llovet, Rosalba Miceli, Sherrie Bhoori, Marcello Schiavo, Luigi Mariani, Tiziana Camerini, Sasan Roayaie, Myron Schwartz, Gian Luca Grazi, René Adam, P. Neuhaus, Mauro Salizzoni, Jordi Bruix, Alejandro Forner, Luciano De Carlis, Umberto Cillo, Andrew K. Burroughs, Roberto Troisi, Massimo Rossi, Giorgio Enrico Gerunda, Jan Lerut, Jacques Belghiti, I. Boin, Jean Gugenheim, Fedja A. Rochling, Bart van Hoek, Pietro Majno
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E. Hutson, Evgeny Kopyltsov, María José Méndez-Vidal, Vadim Kozlov, Anna Alyasova, Sung‐Hoo Hong, Anil Kapoor, Teresa Alonso Gordoa, Jaime R. Merchan, Eric Winquist, Pablo Maroto, Jeffrey C. Goh, Miso Kim, Howard Gurney, Vijay Patel, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Bohuslav Melichar, Frédéric Rolland, Ugo De Giorgi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Corina E. Dutcus, Alan D. Smith, Lea Dutta, Kalgi Mody, Rodolfo F. Perini, Dongyuan Xing, Toni K. Choueiri
Assessment of <sup>68</sup>Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer
Wolfgang P. Fendler, Jérémie Calais, Matthias Eiber, Robert R. Flavell, Ashley Mishoe, Felix Y. Feng, Hao G. Nguyen, Robert E. Reiter, Matthew B. Rettig, Shozo Okamoto, Louise Emmett, Helle D. Zacho, Harun Ilhan, Axel Wetter, Christoph Rischpler, Heiko Schöder, Irene A. Burger, J Gartmann, Raven Smith, Eric J. Small, Roger Slavik, Peter R. Carroll, Ken Herrmann, Johannes Czernin, Thomas A. Hope
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Wolfgang P. Fendler, Matthias Eiber, Mohsen Beheshti, Jamshed Bomanji, Francesco Ceci, Steven Cho, Frederik L. Giesel, Uwe Haberkorn, Thomas A. Hope, Klaus Kopka, Bernd J. Krause, Felix M. Mottaghy, Heiko Schöder, John J. Sunderland, Simon Wan, Hans‐Jürgen Wester, Stefano Fanti, Ken Herrmann
How much of the research on Fondazione IRCCS Istituto Nazionale dei Tumori is open access?
ScholarIQopen access share
75%OPEN ACCESS